Cargando…
2435. The Impact of Treatment Strategy and Toxin Status on Outcomes of Patients with Clostridioides difficile Infections
BACKGROUND: Clostridioides difficile infection (CDI) is an important cause of morbidity and mortality and management continues to evolve. For laboratories that diagnose by detection of toxin gene, it is unclear whether reporting toxin production is additive to patient care. Furthermore, is there sti...
Autores principales: | Friedman, Daniel, Zurek, Karen, Asadi, Leyla, Lee, Mao-Cheng, Hoang, Holly |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809674/ http://dx.doi.org/10.1093/ofid/ofz360.2113 |
Ejemplares similares
-
2435. Stewardship – It’s Not Just Antibiotics and Testing
por: Sampson, Mindy, et al.
Publicado: (2023) -
386. Clostridioides difficile PCR Cycle Threshold to Determine Toxin Positivity Status
por: Crone, Andrew S, et al.
Publicado: (2022) -
2398. Effect of Eosinopenia and Binary Toxin on Clostridioides difficile Infection Clinical Outcomes
por: Carlson, Travis J, et al.
Publicado: (2019) -
839. Effect of Clostridioides difficile (C. difficile) Toxin Test Reporting on Clinical Treatment and Outcomes of Toxin-Negative PCR-Positive Patients at Five California Hospitals
por: Polage, Christopher R, et al.
Publicado: (2019) -
135. Impact of Clostridioides difficile Toxin Confirmation on Subsequent C. difficile Treatment in a Rural Health System (IT-CDI)
por: Crawford, Jacquelyn, et al.
Publicado: (2023)